GB-2064
N/A
Report date: 2022/08/22 20:00:20
NME
Base Information
Drug NameGB-2064
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[5]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPharmakea Inc
China Registration ClassN/A
Develop Information
Active CompaniesGalecto Biotech AB
Inactive CompaniesPharmakea IncThe University Of Texas MD Anderson Cancer Center
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A